Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments
Cancer Research and Treatment. 2016;48(2):727-737 
584 Enhancement of radioresponse of murine tumors by paclitaxel (PAX) or taxotere (TAX)
Lung Cancer. 1997;18:150
Enhancement of Radioresponse of Murine Tumors by ERK Inhibitor
Annals of the New York Academy of Sciences. 2002;973(1):371-373
ER Status of Mouse Mammary Tumors in Different Microenvironments
Annals of Oncology. 2013;24:iii43
40 Altered DNA repair capacity in malignant prostate cells: Implications for genetic transformation and radioresponse
Radiotherapy and Oncology. 2002;65:S9-S10
Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II: in vivo radioresponse following fractionated treatment and in vitro/in vivo correlations
International Journal of Radiation Oncology*Biology*Physics. 1990;18(2):331-345
Characterization of mutant murine lymphoma cells with altered inosinate dehydrogenase activities.
Journal of Biological Chemistry. 1983;258(1):523-528
Different mechanisms can lead to the same altered HLA class I phenotype in tumors
Tissue Antigens. 2007;69:259-263
Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
Journal of Biological Chemistry. 1993;268(31):23585-23592
646 Enhancement of radioresponse by phosphatidylinositol 3-kinase inhibitor in radioresistant murine hepatocarcinoma
European Journal of Cancer Supplements. 2004;2(8):195